Alinam
Alinam Brand names, Alinam Analogs
- Alinam
- Banabil-sintyal
- Banabin
- Banabin-Sintyal
- Banabin-syntyal
- Bisina
- Chlomedinon
- Chlormethazanone
- Chlormethazone
- Chlormezanon
- Chlormezanone [BAN:INN:JAN]
- Chlormezanonum [INN-Latin]
- Clorilax
- Clormetazanone
- Clormetazon
- Clormezanona [INN-Spanish]
- Clormezanone [DCIT]
- Dichloromethazanone
- Dichloromezanone
- Fenarol
- Lobak
- Mio-Sed
- Miorilax
- Muskel
- Muskel-Trancopal
- Myolespen
- Phenarol
- Rexan
- Rilansyl
- Rilaquil
- Rilasol
- Rilassol
- Rilax
- Rillasol
- Supotran
- Suprotan
- Tanafol
- Trancopal
- Trancote
- Tranrilax
- Transanate
- dl-Chlormezanone
Alinam Brand Names Mixture
- No information avaliable
Alinam Chemical_Formula
C11H12ClNO3S
Alinam RX_link
No information avaliable
Alinam fda sheet
Alinam msds (material safety sheet)
Alinam Synthesis Reference
No information avaliable
Alinam Molecular Weight
273.737 g/mol
Alinam Melting Point
116.2 oC
Alinam H2O Solubility
2500 mg/L (hardly soluble)
Alinam State
Solid
Alinam LogP
1.208
Alinam Dosage Forms
No information avaliable
Alinam Indication
Used in the management of anxiety and in the treatment of muscle spasm.
Alinam Pharmacology
Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).
Alinam Absorption
No information avaliable
Alinam side effects and Toxicity
Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
Alinam Patient Information
No information avaliable
Alinam Organisms Affected
Humans and other mammals
